|
|
|
| Effect of Ketotifen combined with Salbutamol in the treatment of children with asthma |
| SONG Yi |
| Department of Pharmacy, the Third Affiliated Hospital of CQMU, Chongqing 401120, China |
|
|
|
|
Abstract Objective To explore the effect of Ketotifen combined with Salbutamol in the treatment of children with asthma.Methods A total of 72 children with asthma admitted in the Third Affiliated Hospital of CQMU from February 2019 to February 2020 were selected as the research objects, and they were divided into a control group (36 cases) and a test group (36 cases) according to the lottery method.The patients in control group were treated with Salbutamol, and the patients in test group were treated with Salbutamol and Ketotifen.The clinical total effectiveness, day and night symptom scores, serum endothelin-1 (ET-1) and circulating endothelial cell (CEC) levels were compared between the two groups.Results The clinical effective rate of test group was higher than that in control group, the difference was statistically significant (P＜0.05).Before treatment, the differences in clinical symptom scores between the two groups were not statistically significant (P＞0.05);after treatment, the clinical symptom scores of two groups were all lower than those before treatment, and the differences were statistically significant (P＜0.05);after treatment, the clinical symptom scores of the test group were lower than those in control group, the differences were statistically significant(P＜0.05).Before treatment, there were no statistically significant differences in the levels of ET-1 and CEC between the two groups(P＞0.05);after treatment, the levels of ET-1 and CEC in two groups were all lower than those before treatment, and the differences were statistically significant (P＜0.05);after treatment, the levels of ET-1 and CEC in test group were lower than those in control group, and the differences were statistically significant (P＜0.05).There was no statistically significant difference in the adverse reaction ratio between the two groups (P＞0.05).Conclusion Ketotifen combined with Salbutamol in the treatment of asthma is helpful to improve the effectiveness of the treatment, improve the clinical symptoms, and has high safety.
|
|
|
|
|
|
| [1] |
吴喜锋，冯高华.咳露口服液联合酮替芬治疗咳嗽变异性哮喘的疗效及对免疫功能、炎症因子水平的影响[J].中国医院用药评价与分析，2020，20（4）：418-420，424.
|
| [2] |
周志杰，赵军华，崔吉冈，等.富马酸酮替芬片联合白三烯受体拮抗剂对咳嗽变异性哮喘患者症状改善及肺功能的影响[J].实用临床医学，2020，21（1）：13-14，24.
|
| [3] |
Bousquet J，Scheinmann P，Guinnepain MT，et al.Sublingual-swallow immunotherapy （SLIT） in patients with asthma due to house-dust mites：a double-blind，placebo-controlled study[J].Allergy，2015，54（3）：249-260.
|
| [4] |
董继军，杨明刚，李冰.丙酸氟替卡松、孟鲁司特钠、酮替芬不同联用方案治疗儿童咳嗽变异性哮喘的临床比较[J].儿科药学杂志，2020，26（3）：18-21.
|
| [5] |
中华医学会呼吸病学分会哮喘学组.支气管哮喘防治指南（支气管哮喘的定义、诊断、治疗和管理方案）[J].中华结核和呼吸杂志，2008，31（3）：177-185.
|
| [6] |
Jisha V，Dampanaboina L，Vadassery J，et al.Recent advances in the treatment of asthma：proceedings of a symposium on Ketotifen held as a part of the Seventh Asia-Pacific Congress on Diseases of the Chest，Hong Kong，November 3，1981[J].PLoS One，2015，10（6）：215-226.
|
| [7] |
朱晓弘，涂金伟，代继宏.丙酸氟替卡松、孟鲁斯特钠、酮替芬治疗儿童咳嗽变异性哮喘的临床疗效观察[J].中国当代儿科杂志，2019，21（4）：393-398.
|
| [8] |
姚嫣，吴丽君，严杰.孟鲁司特与酮替芬联合沙美特罗/氟替卡松治疗咳嗽变异性哮喘的效果比较[J].中国基层医药，2019，26（11）：1357-1359.
|
| [9] |
陈阿阮，程元辉，陈静.沙丁胺醇与酮替芬联合治疗对小儿哮喘血清ET-1 NO CEC水平的影响[J].河北医学，2020，26（3）：437-441.
|
| [10] |
白连霞，郝木红.酮替芬联合布地奈德治疗支气管哮喘的临床疗效及其安全性[J].临床合理用药杂志，2018，11（21）：15-16.
|
| [11] |
江永贤.小儿支气管哮喘急性发作采用沙丁胺醇和布地奈德雾化吸入治疗效果分析[J].中国保健营养，2017，27（1）：10-11.
|
| [12] |
韩俊凤，冯雨，姜冰，等.酮替芬联合沙丁胺醇气雾剂喷吸对咳嗽变异性哮喘患者嗜酸性粒细胞趋化因子与肺功能的影响[J].现代生物医学进展，2018，18（20）：127-131.
|
| [13] |
赵克伟.沙丁胺醇气雾剂联合富马酸酮替芬片治疗小儿咳嗽变异性哮喘[J].河南医学研究，2019，28（14）：2601-2602.
|
| [14] |
解静，韦钰.观察沙丁胺醇结合酮替芬用于小儿哮喘治疗中的效果[J].中国保健营养，2016，26（33）：263-264.
|
| [15] |
马丽放.富马酸酮替芬联合沙美特罗替卡松对变应性鼻炎并支气管哮喘患者肺功能及生活质量的影响[J].数理医药学杂志，2020，33（2）：285-286.
|
|
|
|
